Treatment features of adult patients with acute myeloid leukemia during the COVID-19 pandemic
Background. Acute myeloid leukemia (AML) is a highly aggressive oncological disease of the blood and bone marrow, requiring extremely toxic chemotherapy and massive supportive treatment to achieve stable remission. Currently, there is no work to provide medical care to these patients with a high ris...
Saved in:
| Main Authors: | D. E. Gagloeva, E. N. Misyurina, T. N. Tolstykh, E. A. Baryakh, K. V. Yatskov, E. A. Karimova, A. B. Makeshova, M. A. Mingalimov, T. S. Chudnova, D. D. Ivanova, A. I. Koneva, O. L. Kochneva, E. N. Zotina, E. Yu. Grishina, L. T. Shimanovskaya, V. N. Yakimets, E. I. Zhelnova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-01-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/887 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment experience of coronavirus infection associated with SARS-CoV-2 in patients with acute myeloid leukemia in the older age group
by: L. T. Shimanovskaya, et al.
Published: (2024-01-01) -
Treatment of elderly patients with acute myeloid leukemia: personal experience
by: L. T. Shimanovskaya, et al.
Published: (2024-12-01) -
COVID-19 in patients with acute leukemia: 3 years' experience of pandemic
by: T. S. Chudnova, et al.
Published: (2024-01-01) -
COVID-19 in patients with acute lymphoblastic leukemia
by: T. S. Chudnova, et al.
Published: (2024-09-01) -
Treatment efficiency in patients with acute myeloid leukemia from 2019 to 2023 according to the Moscow Cancer Registry
by: T. N. Tolstykh, et al.
Published: (2024-09-01)